Log in to save to my catalogue

Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models

Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7a3835df015d40f0a03de6f8a36ed636

Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models

About this item

Full title

Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models

Publisher

Singapore: Springer Nature Singapore

Journal title

Cell discovery, 2022-04, Vol.8 (1), p.38-38, Article 38

Language

English

Formats

Publication information

Publisher

Singapore: Springer Nature Singapore

More information

Scope and Contents

Contents

The global COVID-19 epidemic has spread rapidly around the world and caused the death of more than 5 million people. It is urgent to develop effective strategies to treat COVID-19 patients. Here, we revealed that SARS-CoV-2 infection resulted in the dysregulation of genes associated with NAD
+
metabolism, immune response, and cell death in mi...

Alternative Titles

Full title

Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7a3835df015d40f0a03de6f8a36ed636

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7a3835df015d40f0a03de6f8a36ed636

Other Identifiers

ISSN

2056-5968

E-ISSN

2056-5968

DOI

10.1038/s41421-022-00409-y

How to access this item